Observational analysis found high adherence to stool DNA screening in patients, suggesting improved strategies for follow-up completion.
High mt-sDNA adherence and timely FU-CY completion suggest mt-sDNA is an effective, patient-acceptable option for colorectal cancer screening. However, disparities by age, race/ethnicity, income, and patient return history highlight the need for targeted outreach strategies to improve screening equity and follow-up completion.
No takes yet. Share an insight, caveat, or question.
Greene et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: